)
Killian Hanlon
CEO & Chief Scientist,
Lir Therapeutics
Sessions
-
Panel Discussion: Designing the Next Generation of Rare Disease Therapies: From Advanced Genomics to AI-Enabled Therapeutic Innovation27-Jan-2027Advanced Therapies Stage